Pharmaceuticals, maxi-acquisition of the Japanese Takeda: buy the Irish Shire for 52 billion
It is a record for a Japanese operation. So the company that has more than two centuries of life focuses on rare diseases and development in 
North America, launching the challenge to the two big USA Pfizer and AbbVie.
The Japanese pharmaceutical company Takeda has reached an agreement to acquire the Irish Shire Plc for 46 billion pounds, the equivalent of 52 billion euros: this is the largest foreign acquisition by a Japanese company. On April 25, Takeda had decided to make a fifth increase attempt by deciding to postpone the expiry of the offer to May 8.
(… continue on La Repubblica Economy & Finance of 8 May 2018)
Related news: Takeda Clinches $62 Billion Deal to Buy Drugmaker Shire
Aurobindo offers $1.6 billion for Novartis dermatological generics
